DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Giuliani N, Morandi F, Tagliaferri S. et al.
The proteasome inhibitor bortezomib affects osteoblast differentiation in vitro and in vivo in multiple myeloma patients.
Blood 2007; 110 (1): 334-338
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.